Glucocorticoid exacerbation of gp120 neurotoxicity: role of microglia

Sheila M Brooke1, Robert M Sapolsky

  • 1Department of Biological Sciences, Stanford University, Stanford, California 94305, USA. Sheila.Brooke@Stanford.edu

Experimental Neurology
|November 14, 2002
PubMed

Insights

Glucocorticoids (GCs) worsen HIV's gp120 protein-induced neurotoxicity, potentially causing AIDS-Related Dementia (ARD). GCs affect microglia and neurons, with effects varying based on exposure time.

Area of Science:

  • Neuroscience
  • Immunology
  • Endocrinology

Background:

  • HIV gp120 protein is implicated in AIDS-Related Dementia (ARD) due to its neurotoxicity.
  • Potential mechanisms include microglial toxin release or direct neuronal action.
  • Glucocorticoids (GCs), stress hormones, are known to exacerbate gp120 neurotoxicity in vitro.

Purpose of the Study:

  • To investigate how GCs enhance gp120-induced neurotoxicity.
  • To examine the interaction between GCs, microglia, and neurons.

Main Methods:

  • Utilized tissue culture models with microglia and neurons.
  • Exposed microglia to gp120 and GCs for varying durations.
  • Assessed the neurotoxic effects of conditioned media from treated microglia.

Main Results:

  • Media from gp120-treated microglia was toxic to neurons.
  • GC exposure duration influenced microglial toxin release: 24-hour exposure decreased toxicity, while longer exposure increased it.
  • GCs exacerbated gp120 neurotoxicity independently of microglia in hippocampal cultures.

Conclusions:

  • GCs exacerbate gp120 neurotoxicity through multiple pathways involving microglia and neurons.
  • The time-dependent effects of GCs highlight complex interactions in ARD pathogenesis.